Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@MMMnews
mmm-online.com-online.com

Why procurement, pharma marketers and agencies need to get along

1+ mon, 2+ week ago   (1442+ words) Agencies want their procurement partners to co-create with them along every step of the process, rather than simply providing a mandate. As agencies continue to invest in AI, they’re finding that their conversations with procurement are shifting from how the…...

@HealthcareDig
healthcare-digital.com

How Dassault Systèmes is Closing a Critical Pharma Data Loop

1+ mon, 2+ week ago   (459+ words) Following its US$2bn acquisition of AI-native compliance platform ArisGlobal, international software giant Dassault Systèmes believes it can break down one of the pharmaceutical and life sciences industry's most persistent data silos. ArisGlobal’s platform serves over 200 customers, including half of the…...

Google News
deepsense.ai > industry > clinical-trials

Clinical Trials Archives

1+ mon, 2+ week ago   (724+ words) Explore all the technology expertise we have to develop AI solutions Deploy Agentic RAG Pipelines in Minutes with ragbits Get to know us, our leadership, development direction, and why we call ourselves applied AI experts. Look at our open positions…...

The Gateway Pundit
thegatewaypundit.com > 2026 > 07 > groundbreaking-cancer-study-that-big-pharma-doesnt-want-4

The Groundbreaking Cancer Study That Big Pharma Doesn’t Want You To Know About * The Gateway Pundit * by Promoted Post

1+ mon, 2+ week ago   (76+ words) (Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits…...

FindArticles
findarticles.com > how-independent-review-platforms-consistently-recognize-tekrevol

How Independent Review Platforms Consistently Recognize TekRevol

1+ mon, 2+ week ago   (1031+ words) Washington DC runs on verification. Ask anyone who’s worked with a federal contractor, a policy association, or a nonprofit headquartered here, and they’ll tell you the same thing: nobody takes a claim at face value until it’s been checked. That…...

Women's Health
womenshealthmag.com > health > a73/23/7854 > diy-healthcare-rise-wellness-trends

What Happens When the Internet Becomes Your Doctor? A Look Into the Rise of DIY Healthcare

1+ mon, 2+ week ago   (1494+ words) More women are taking wellness into their own hands—but at what cost? FOR 18 MONTHS, Kate Hinkens’s mornings began with the same ritual. Every other day, the now 32-year-old would use a mirror to carefully position up to 10 bees on…...

TNW | Anthropic
thenextweb.com > news > icon-anthropic-claude-clinical-trials-enrolment-bottleneck

Anthropic's new pharma deal targets paperwork, not molecules

1+ mon, 2+ week ago   (186+ words) ICON will deploy Claude across 40,200 staff running clinical trials. Anthropic says enrolment, not science, delays up to 80% of them....

Google News
pharmexec.com > view > operation-trialblazer-clinical-trials-leaving-richard-graham

Operation Trialblazer and Why Clinical Trials are Leaving the US: Q&A with Richard Graham

1+ mon, 2+ week ago   (444+ words) TruTechnologies chairman and co-founder argues that while Operation TrialBlazer is directionally correct in targeting regulatory friction, it misses the larger problem. FDA’s latest initiative to improve the drug approval process is Project Trialblazer. The pilot program is designed to accelerate…...

STAT
statnews.com > 07/28/2026 > three-questions-with-whoops-new-cmo-health-tech

Three questions with Whoop's new CMO

1+ mon, 2+ week ago   (140+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...

RAPS
raps.org > resource > recon-who-releases-first-interim-list-of-medical-device-authorities-astrazeneca-using-ai-to-hedge-late-stage-risks.html

Recon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks

1+ mon, 2+ week ago   (146+ words) Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is published each week on Monday, Tuesday and Thursday. A story’s inclusion…...